# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000906709-21-000005
Filing Date
2021-02-26
Accepted
2021-02-25 19:16:36
Documents
89
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nktr-20201231.htm iXBRL | 10-K | 2417381
2 | EX-10.35 | nktr20201231-exx1035.htm | EX-10.35 | 605410
3 | EX-10.39 | nktr20201231-exx1039.htm | EX-10.39 | 523395
4 | EX-23.1 | nktr20201231-exx231.htm | EX-23.1 | 5281
5 | EX-31.1 | nktr-20201231xexx311.htm | EX-31.1 | 8099
6 | EX-31.2 | nktr-20201231xexx312.htm | EX-31.2 | 8142
7 | EX-32.1 | nktr-20201231xexx321.htm | EX-32.1 | 6363
13 | GRAPHIC | image_01a.jpg | GRAPHIC | 8470
14 | GRAPHIC | nktr-20201231_g1.jpg | GRAPHIC | 179012
| Complete submission text file | 0000906709-21-000005.txt |  | 11963360

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | nktr-20201231.xsd | EX-101.SCH | 82977
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | nktr-20201231_cal.xml | EX-101.CAL | 113700
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | nktr-20201231_def.xml | EX-101.DEF | 329145
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | nktr-20201231_lab.xml | EX-101.LAB | 875548
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | nktr-20201231_pre.xml | EX-101.PRE | 533429
15 | EXTRACTED XBRL INSTANCE DOCUMENT | nktr-20201231_htm.xml | XML | 1661978

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 21682647
SIC: 2834 Pharmaceutical Preparations